You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

First 1,000 days

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Infant Trial in New York (Behavior Change Intervention)

Recruiting
  • Obesity, Infant
  • Behavior Change Intervention
  • New York, New York
    Columbia University
Feb 3, 2022

Overweight and Obesity, Social Determinants of Health, Physical Activity Trial (First 1,000 Days Program Site)

Completed
  • Overweight and Obesity
  • +5 more
  • First 1,000 Days Program Site
  • (no location specified)
Sep 10, 2021

Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine

Recruiting
  • Triple Negative Breast Cancer
  • Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
  • Gemcitabine combined with carboplatin plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 6, 2022

Infertility Trial in Guangzhou (GenSci094, Placebo RecFSH / follitropin alfa, Biological: RecFSH / Follitropin alfa (Days 1 to

Recruiting
  • Infertility
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital, Sun Yat-sen University Guangdong
Oct 17, 2023

Stunting, Anemia, Micronutrient Deficiency Trial in Kakamega (Intervention (integrated package), Control)

Unknown status
  • Stunting
  • +2 more
  • Intervention (integrated package)
  • Control
  • Kakamega, Kenya
    One Acre Fund
Feb 3, 2020

Healthy Trial in Adelaide (ENN0403 1mg, ENN0403 4mg, ENN0403 10mg)

Completed
  • Healthy
  • ENN0403 1mg
  • +9 more
  • Adelaide, Australia
    CMAX Clinical Research Pty Ltd
Aug 17, 2022

Shaping Microbiome in the First 1,000 Days of Life

Completed
  • Microbial Colonization
    • Pavia, Italy
      IRCCSSMP
    Oct 9, 2019

    Metastatic Pancreatic Cancer Trial in Fairhaven, Providence (FOLFOXA)

    Completed
    Has Results
    • Metastatic Pancreatic Cancer
    • Fairhaven, Massachusetts
    • +1 more
    Jul 27, 2022

    The Right Care, for Right Patient, at Right Time, by Right

    Not yet recruiting
    • Ambulatory Care
    • +3 more
    • On-site recruitment (information and consent) following a random sampling recruitment schedule
    • +2 more
    • Kingston, Ontario, Canada
    • +6 more
    May 26, 2023

    Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to Trial in Karachi (Sequential Regimen:

    Completed
    • Helicobacter Pylori Infection
    • Helicobacter Pylori Infection, Susceptibility to
    • Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID
    • Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID
    • Karachi, Sindh, Pakistan
      Jamal Noor Hospital, Karachi
    May 8, 2023

    Gastroenteropancreatic Neuroendocrine Tumor Trial in China (Lanreotide autogel)

    Completed
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Lanreotide autogel
    • Sichuan, Chengdu, China
    • +13 more
    Jan 16, 2023

    Local Anesthesia Trial in Cairo (4% Articaine Hydrochloride with 1:100,000 Adrenaline, 2% Mepivacaine Hydrochloride with

    Recruiting
    • Local Anesthesia
    • 4% Articaine Hydrochloride with 1:100,000 Adrenaline
    • 2% Mepivacaine Hydrochloride with 1:20,000 Levonordefrin
    • Cairo, Egypt
      Faculty of dentistry cairo university
    Aug 6, 2021

    NSCLC Trial in China (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

    Active, not recruiting
    Has Results
    • Non-small Cell Lung Cancer
    • Pembrolizumab
    • +2 more
    • Hefei, Anhui, China
    • +16 more
    Oct 14, 2022

    Two Domestic HPV Vaccines and Imported HPV Vaccines in Women

    Not yet recruiting
    • HPV Infection
    • +2 more
    • Follow up
    • Fuzhou, Fujian, China
      Fujian Maternity and Child Health Hospital
    Nov 16, 2023

    ST Elevation Myocardial Infarction Trial in Worldwide (MEDI6012, Placebo)

    Completed
    Has Results
    • ST Elevation Myocardial Infarction
    • MEDI6012
    • Placebo
    • Belo Horizonte, Brazil
    • +36 more
    Jan 13, 2022

    Advanced Solid Tumors, EGFR Positive NSCLC, Colorectal Carcinoma Trial in United States (TP-0903)

    Active, not recruiting
    • Advanced Solid Tumors
    • +4 more
    • Phoenix, Arizona
    • +15 more
    Apr 4, 2022

    Cervical Cancer Trial in Worldwide (Cemiplimab, ISA101b)

    Recruiting
    • Cervical Cancer
    • Tucson, Arizona
    • +31 more
    Jul 22, 2022

    Pregnancy Related, Infant Development Trial in New York (Mobile messaging)

    Completed
    • Pregnancy Related
    • Infant Development
    • Mobile messaging
    • New York, New York
      Columbia University
    Nov 8, 2021

    Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)

    Active, not recruiting
    Has Results
    • Urothelial Cancer
    • MEDI4736 (Durvalumab)
    • +4 more
    • Los Angeles, California
    • +221 more
    Nov 2, 2022

    Trends In Oxygen Saturation In Healthy Term Infants In The First

    Completed
    • Normative Oxygen Saturation Data Will Help us in
    • +3 more
      • Calgary, Alberta, Canada
      • +3 more
      Mar 28, 2021

      Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)

      Completed
      Has Results
      • Rheumatoid Arthritis (RA)
      • Curitiba, Parana, Brazil
      • +42 more
      Aug 30, 2021

      HIV Trial in Puerto Rico, United States (NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs

      Completed
      Has Results
      • HIV Infections
      • NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)
      • +2 more
      • Alhambra, California
      • +30 more
      Nov 3, 2021

      Pain, Post Operative, Quality of Life Trial (Ibuprofen 600 mg, Placebo, Acetaminophen)

      Not yet recruiting
      • Pain, Post Operative
      • Quality of Life
      • Ibuprofen 600 mg
      • +2 more
      • (no location specified)
      Jun 24, 2023

      MR-proADM and CT-proET-1 During ICU Treatment

      Completed
      • Acute Phase Biomarkers
      • Medical ICU Admitted Patients
      • Blood sampling for MR-proADM & CT-proET-1
      • Zurich, ZH, Switzerland
        University Hospital Zurich, Medical intensive care unit
      May 27, 2021

      NSCLC Trial in Worldwide (Tislelizumab, Docetaxel)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Salvador, Bahia, Brazil
      • +85 more
      Jun 23, 2022